ACHP Letter to Acting FDA Commissioner on the Accelerated Approval of Drugs and Biologics

March 6, 2025

ACHP sent a letter to FDA’s Acting Commissioner, Sara Brenner, with comments on the Expedited Program for Serious Conditions.

Loading...

Taking too long?

Reload document

|

Open in new tab

Download the Letter